ArticleClinical and translational science2022

Pharmacokinetic/pharmacodynamic modeling for dose selection for the first-in-human trial of the activated Factor XII inhibitor garadacimab (CSL312).

Dipti Pawaskar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.